Latest Articles
- A 62-year-old man with sudden onset of orthopnea and left shoulder weakness and pain
What is the cause of this patient’s symptoms? A self-test.
Alosetron (Lotronex) is back: Should I use it to treat my patients with irritable bowel syndrome?The FDA recently approved the remarketing of alosetron, but with strict limitations.
- Relieving migraine pain: Sorting through the options
Even with effective treatments, including new drugs in convenient dosage forms, the key is still a good working patient-physician relationship.
- New guidelines: What to do about an unexpected positive tuberculin skin test
With tuberculosis declining in prevalence, the focus is shifting to testing only persons at increased risk.
- Who is conducting the deadly quartet?
The metabolic syndrome warrants aggressive intervention and prevention, even if we cannot explain it yet.
- The metabolic syndrome: A tug-of-war with no winner
Even before beta cells fail, the deadly quartet is quietly rehearsing.
- The HIP trial
Patients should be selected for bisphosphonate therapy on the basis of low bone density, not age.
